Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.
about
Molecular pathology of prostate cancerIdentification of proteins in laser-microdissected small cell numbers by SELDI-TOF and Tandem MSDiagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral DataA data review and re-assessment of ovarian cancer serum proteomic profilingApplication of serum SELDI proteomic patterns in diagnosis of lung cancerLaser capture microdissection: Big data from small samplesApplication and implementation of selective tissue microdissection and proteomic profiling in neurological disease.Preliminary study on proteomics of gastric carcinoma and its clinical significance.Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range.Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MSDiscovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia.the need for review and understanding of SELDI/MALDI mass spectroscopy data prior to analysis.The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasiaProstate-specific antigen, digital rectal examination and transrectal ultrasonography: a meta-analysis for this diagnostic triad of prostate cancer in symptomatic korean men.Searching for Potential Ovarian Cancer Biomarkers with Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.A classification method based on principal components of SELDI spectra to diagnose of lung adenocarcinomaAnalysis of ovarian tumor pathology by Fourier Transform Infrared Spectroscopy.Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.A Mass Spectrometric Analysis Method Based on PPCA and SVM for Early Detection of Ovarian Cancer.State of the art in tumor antigen and biomarker discovery.Proteomic Workflows for Biomarker Identification Using Mass Spectrometry - Technical and Statistical Considerations during Initial Discovery.Inflammation: an important parameter in the search of prostate cancer biomarkers.Depicting the spatial distribution of proteins in human tumor tissue combining SELDI and MALDI imaging and immunohistochemistry.Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor.
P2860
Q24672410-1ADA9C3C-9A5F-4C56-BD48-1EF41F1DDAEFQ24792088-F43A6EFA-27C9-4031-A795-A23A5E397EB7Q24798791-0F6BE3F1-7904-47B3-8A14-0FD0EE556434Q24806513-41BDBCB0-0D87-4071-B505-157FF86D1080Q24810545-1EA95B9F-77D1-476B-8F98-AEFACBEE161FQ27004268-0B14032F-7383-4386-A292-C51D996094BAQ30360876-7404C6B7-1414-4A05-9D66-488D0ABA3EFDQ33231849-F0F2949A-C262-4D24-9CD8-37FB83ACD5FCQ33301709-85E55FAC-E7CF-4868-897E-C292A42EB18DQ33326878-5DE375C1-50D4-4627-9BA2-44C5FDCB3D79Q33418760-35DE392D-B539-47A4-AAC9-88D0F5A2D82BQ33420435-01C03B41-ACE2-465C-A086-AB39C3602CB5Q33493120-AB05BFC5-FF33-49AE-8735-1E0233B36A55Q33628178-F1D993A8-8517-416A-A091-FD41BB238392Q33642806-0C3424B6-77A6-4EBB-885F-6E887DE8AAD9Q34213878-E8C5983A-DADC-4AC2-B3D5-54A3E74B078BQ34471302-DCCED47C-4F65-45B5-B5D7-99F56AD3ADD6Q35873154-F5442091-80C3-4E02-B0EA-117E73984DD1Q36136903-6A00BA5B-30D7-4113-B0FD-563BBF31B2CCQ37132800-C04DC68E-0D90-4C93-AA27-68EE32D2C909Q37636447-5B031DF9-2B0B-41D9-837F-F5DFC6EF622EQ40834431-853519FD-6154-4E55-A34E-F4AF9A218212Q42424403-B473B4D6-93FE-4D9F-987D-0C0E003AC868Q42762135-84961125-89B3-4FB1-B0C7-BB8E0F85DA27
P2860
Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Normal, benign, preneoplastic, ...... /ionization mass spectrometry.
@ast
Normal, benign, preneoplastic, ...... /ionization mass spectrometry.
@en
type
label
Normal, benign, preneoplastic, ...... /ionization mass spectrometry.
@ast
Normal, benign, preneoplastic, ...... /ionization mass spectrometry.
@en
prefLabel
Normal, benign, preneoplastic, ...... /ionization mass spectrometry.
@ast
Normal, benign, preneoplastic, ...... /ionization mass spectrometry.
@en
P2093
P1476
Normal, benign, preneoplastic, ...... n/ionization mass spectrometry
@en
P2093
Bao-Ling Adam
George L Wright
Michael D Ward
O John Semmes
Paul F Schellhammer
Suhail Nasim
P304
P407
P577
2002-08-01T00:00:00Z